Our department conducts a robust research program that fosters a culture of innovation and collaboration.

The UAB Department of Urology is actively involved in both clinical, basic science, and translational research endeavors. We have a large tissue and biologic fluids library of hundreds of urologic cancer specimens for internal study. This repository is a basis through which we are attempting to identify markers and characteristics to stratify patients into risk groups. We are also investigating renal ischemia in an animal model to identify means of optimizing renal function and markers that predict outcomes.  

The Department of Urology participates in multiple clinical trials. We are members of the Eastern Cooperative Oncology Group and Early Detection Research Network (branch of the National Cancer Institute), actively involved in multi-institutional studies in urologic cancer. Our translational involvement in chemoprevention studies of bladder and prostate cancer is part of the chemoprevention consortium of our NCI Comprehensive Cancer Center. We participate in numerous non-cancer studies including investigating the feasibility of tissue engineering and the role of bladder replacement in both pediatric and neuro-urology patient populations.

For more information on these studies, including how to enroll, please contact Demond Wiley, research coordinator, at 205-934-5712 or email kidneystone@uabmc.edu.

We also have a state-of-the-art kidney stone laboratory with multiple NIH-funded scientists studying kidney stone disease.